Corrigendum to "Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study" [Sleep Med. 109 (2023) 65-74 ISSN 1389-9457]
Sleep Med
.
2024 Jul:119:17-18.
doi: 10.1016/j.sleep.2024.04.001.
Epub 2024 Apr 16.
Authors
Charles J Bae
1
,
Phyllis C Zee
2
,
Eileen B Leary
3
,
Douglas S Fuller
4
,
Wayne Macfadden
4
,
Shawn Candler
5
,
Teresa L Steininger
3
,
Aatif M Husain
6
Affiliations
1
Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
2
Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
3
Jazz Pharmaceuticals, Palo Alto, CA, USA.
4
Jazz Pharmaceuticals, Philadelphia, PA, USA.
5
Jazz Pharmaceuticals, Philadelphia, PA, USA. Electronic address: Shawn.Candler@jazzpharma.com.
6
Duke University Medical Center, Durham, NC, USA.
PMID:
38631160
DOI:
10.1016/j.sleep.2024.04.001
No abstract available
Publication types
Published Erratum